Xencor
Dong Hyun Nam is a seasoned professional in antibody engineering with extensive experience at Xencor since March 2017, where roles have included Sr. Scientist, Scientist II, Scientist, and Associate Scientist. Prior to this, Dong Hyun Nam served as a Postdoctoral Researcher at the University of California, Riverside from July 2015 to March 2017. Educational credentials include a Ph.D. in Chemical and Environmental Engineering from the University of California, Riverside (2010-2015), a Master of Engineering in Chemical Engineering from Kwangwoon University (2008-2010), and a Bachelor of Engineering in Chemical Engineering from Kwangwoon University (1999-2007).
Xencor
2 followers
Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.